Evaluation of CIMAvaxEGF for the treatment of lung cancer: Meta-analysis of controlled clinical trials

Article

Abstract: CIMAvaxEGF is a therapeutic cancer vaccine developed in Cuba and fully licensed in the country for u

Palabras claves:

EGF receptor, Epidermal growth factor, immunotherapy, Of non-small cell lung cancer vaccine therapy, Oncology vaccines

Autores:

Aliuska Frías, Ballesteros J., Bárbara Wilkinson, Camilo Rodríguez, Carmen Elena Viada, Mabel Álvarez, Martha M. Fors-López, Neninger Vinageras E., Quintero J., Robaina M., Tania Crombet

Fuentes:

scopus